Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 31, 1996 - Issue 10
Submit an article Journal homepage
49
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Fecal Marker Variability in Colorectal Cancer: Calprotectin versus Hemoglobin

J. A. Gilbert Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
,
D. A. Ahlquist Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
,
D. W. Mahoney Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
,
A. R. Zinsmeister Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
,
J. Rubin Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
&
R. D. Ellefson Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
Pages 1001-1005 | Received 07 Mar 1996, Accepted 28 May 1996, Published online: 08 Jul 2009

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

B. Johne, O. Kronborg, H. I. Tøn, J. Kristinsson, P. Fuglerud. (2001) A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method. Scandinavian Journal of Gastroenterology 36:3, pages 291-296.
Read now

Articles from other publishers (29)

Nathalie Blad, Richard Palmqvist & Pontus Karling. (2022) Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study. BMC Cancer 22:1.
Crossref
Fiona A. Ross, James H. Park, David Mansouri, Emilie Combet, Paul G. Horgan, Donald C. McMillan & Campbell S. D. Roxburgh. (2022) The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. BMC Gastroenterology 22:1.
Crossref
Yee Man Kan, Sin Yan Chu & Ching Kong Loo. (2021) Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases. JGH Open 5:6, pages 647-652.
Crossref
Zoe Vincent, Steve Hornby, Susan Ball, Grant Sanders & Ruth M Ayling. (2015) Faecal calprotectin as a marker for oesophago-gastric cancer. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 52:6, pages 660-664.
Crossref
Emily K. Wright, Peter De Cruz, Richard Gearry, Andrew S. Day & Michael A. Kamm. (2014) Fecal Biomarkers in the Diagnosis and Monitoring of Crohnʼs Disease. Inflammatory Bowel Diseases 20:9, pages 1668-1677.
Crossref
G. D. Naismith, L. A. Smith, S. J. E. Barry, J. I. Munro, S. Laird, K. Rankin, A. J. Morris, J. W. Winter & D. R. Gaya. (2013) A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease. Alimentary Pharmacology & Therapeutics 37:6, pages 613-621.
Crossref
Ching-Seng Ang & Edouard C. Nice. (2010) Targeted In-Gel MRM: A Hypothesis Driven Approach for Colorectal Cancer Biomarker Discovery in Human Feces. Journal of Proteome Research 9:9, pages 4346-4355.
Crossref
Gianmichele Meucci, Renata D’Incà, Roberto Maieron, Nicoletta Orzes, Maurizio Vecchi, Daniela Visentini, Giorgio Minoli, Elisabetta Dal Pont, Maurizio Zilli, Elvio Benedetti, Tiziana Virgilio & Elio Tonutti. (2010) Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study. Digestive and Liver Disease 42:3, pages 191-195.
Crossref
Ariella Bar-Gil Shitrit, Dan Braverman, Halina Stankiewics, David Shitrit, Nir Peled & Kalman Paz. (2007) Fecal Calprotectin as a Predictor of Abnormal Colonic Histology. Diseases of the Colon & Rectum 50:12, pages 2188-2193.
Crossref
R. Justin Davies, Richard Miller & Nicholas Coleman. (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nature Reviews Cancer 5:3, pages 199-209.
Crossref
Neal K. Osborn & David A. Ahlquist. (2005) Stool screening for colorectal cancer: Molecular approaches. Gastroenterology 128:1, pages 192-206.
Crossref
T Mak, F Lalloo, D G R Evans & J Hill. (2004) Molecular stool screening for colorectal cancer. British Journal of Surgery 91:7, pages 790-800.
Crossref
Dirk Foell, Michael Frosch, Clemens Sorg & Johannes Roth. (2004) Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clinica Chimica Acta 344:1-2, pages 37-51.
Crossref
Paul J Limburg, Mary E Devens, Jonathan J Harrington, Nancy N Diehl, Douglas W Mahoney & David A Ahlquist. (2003) Prospective Evaluation of Fecal Calprotectin As A Screening Biomarker for Colorectal Neoplasia. American Journal of Gastroenterology 98:10, pages 2299-2305.
Crossref
ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL & MAGNE K FAGERHOL. (2003) Emerging role of calprotectin in gastroenterology. Journal of Gastroenterology and Hepatology 18:7, pages 756-762.
Crossref
Antonio Carroccio, Giuseppe Iacono, Mario Cottone, Lidia Di Prima, Fabio Cartabellotta, Francesca Cavataio, Calogero Scalici, Giuseppe Montalto, Gaetana Di Fede, GiovamBattista Rini, Alberto Notarbartolo & Maurizio R Averna. (2003) Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Study in Adults and Children. Clinical Chemistry 49:6, pages 861-867.
Crossref
Betty L. Herndon, Suhail Abbasi, David Bennett & David Bamberger. (2003) Calcium-binding proteins MRP 8 and 14 in a Staphylococcus aureus infection model: Role of therapy, inflammation, and infection persistence. Journal of Laboratory and Clinical Medicine 141:2, pages 110-120.
Crossref
Jeremy A. Tibble, Gudmundur Sigthorsson, Russell Foster, Ian Forgacs & Ingvar Bjarnason. (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123:2, pages 450-460.
Crossref
David A Ahlquist & Anthony P Shuber. (2002) Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clinica Chimica Acta 315:1-2, pages 157-168.
Crossref
Einar Husebye, Hege Ton & Berit Johne. (2001) Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm1. The American Journal of Gastroenterology 96:9, pages 2683-2687.
Crossref
Konrad K. Richter, Junru Wang, Magne K. Fagerhol & Martin Hauer-Jensen. (2001) Radiation-induced granulocyte transmigration predicts development of delayed structural changes in rat intestine. Radiotherapy and Oncology 59:1, pages 81-85.
Crossref
Magne K Fagerhol. (2000) Calprotectin, a faecal marker of organic gastrointestinal abnormality. The Lancet 356:9244, pages 1783-1784.
Crossref
Szabolcs Ott� & S�ndor Eckhardt. (2000) Early detection for colorectal cancer: New aspects in fecal occult blood screening. Journal of Surgical Oncology 75:3, pages 220-226.
Crossref
Hege Tøn, Øystein Brandsnes, Siri Dale, Jostein Holtlund, Eugenia Skuibina, Henning Schjønsby & Berit Johne. (2000) Improved assay for fecal calprotectin. Clinica Chimica Acta 292:1-2, pages 41-54.
Crossref
David A. Ahlquist, Jonathan J. Harrington, Lawrence J. Burgart & Patrick C. Roche. (2000) Morphometric analysis of the “mucocellular layer” overlying colorectal cancer and normal mucosa: Relevance to exfoliation and stool screening. Human Pathology 31:1, pages 51-57.
Crossref
Jiři Stulik, Jan Österreicher, Kamila Koupilová, Jiři Knižek, Alesš Macela, Jan Bureš, Pavel Jandik, František Langr, Karel Dědiˇ & Peter R. Jungblut. 1999. From Genome to Proteome. From Genome to Proteome 467 474 .
Mihailo Alic. (1999) Is Fecal Calprotectin the Next Standard in Inflammatory Bowel Disease Activity Tests?. American Journal of Gastroenterology 94:11, pages 3370-3371.
Crossref
Jiří Stulík, Jan Österreicher, Kamila Koupilová, Jiří Knížek, Aleš Macela, Jan Bureš, Pavel Jandík, František Langr, Karel Dědič & Peter R. Jungblut. (1999) The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: The S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 20:4-5, pages 1047-1054.
Crossref
Jon Kristinsson, Arne Røseth, Magne Kr. Fagerhol, Erling Aadland, Henning Schjønsby, Ole P. Børmer, Nils Raknerud & Knut Nygaard. (1998) Fecal calprotectin concentration in patients with colorectal carcinoma. Diseases of the Colon & Rectum 41:3, pages 316-321.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.